- US-listed companies
- REGENEREX PHARMA, INC.
- Balance sheet
REGENEREX PHARMA, INC. (RGPX) Balance sheet
Market cap
P/E ratio
| 2011/11 | 2012/11 | 2013/11 | 2014/11 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Cash and cash equivalents | - | 7,780 | 157 | 1,319 | 1,728 | 88,546 | 5,460 | 6,902 | 2,640 | 1,135 | 372 | 653,025 |
| Total cash & short-term investments | - | 7,780 | 157 | 1,319 | 1,728 | 88,546 | 5,460 | 6,902 | 2,640 | 1,135 | 372 | 653,025 |
| Inventories | - | - | - | - | - | - | 246,691 | - | - | - | - | - |
| Total current assets | 1,783 | 11,274 | 50,990 | - | 1,728 | 97,616 | 252,151 | 8,115 | 7,896 | 1,135 | 2,912 | 653,375 |
| Total assets | 76,783 | 65,441 | 157 | 3,819 | 15,069 | 105,623 | 259,167 | 10,470 | 15,322 | 6,539 | 766,680 | 1 |
| Accounts payable | - | - | - | - | 37,870 | 38,348 | 51,098 | 48,038 | 63,027 | 75,145 | 116,760 | 197,673 |
| Total current liabilities | 199,123 | 815,097 | - | - | 336,175 | 405,308 | 518,718 | 621,319 | 660,453 | 776,782 | 4 | 5 |
| Long-term debt, non-current | - | - | - | - | - | - | - | - | - | - | 184,232 | - |
| Total liabilities | - | - | 2 | 799,214 | - | 475,308 | 740,441 | 845,496 | 1 | 1 | 5 | 5 |
| Retained earnings | -105,837 | -105,837 | -105,837 | -105,837 | -1,180,182 | -1,273,761 | -1,385,350 | -1,739,102 | -1,934,693 | -2,072,023 | -5,615,850 | -8,142,891 |
| Stockholders' equity | - | -749,656 | -1,700,132 | -795,395 | -321,106 | -369,685 | -481,274 | -835,026 | -985,617 | -1,122,947 | -4,061,826 | -4,156,205 |